Sonja E. Leonhard, Melissa R. Mandarakas, Francisco de Assis Aquino Gondim, Kathleen Bateman et al.
Guillain-Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics i...
Nowshin Papri, Zhahirul Islam, Sonja E. Leonhard, Quazi Deen Mohammad et al.
The epidemiology, clinical characteristics, management and outcome of Guillain–Barré syndrome (GBS) differ between low-income and middle-income countries (LMIC) and high-income countries (HIC). At present, limited data are available on GBS in LMIC and the true incidence of GBS in many LMIC remains u...
Alex Y. Doets, Hester F. Lingsma, Christa Walgaard, Badrul Islam et al.
BACKGROUND AND OBJECTIVES: The clinical course and outcome of the Guillain-Barré syndrome (GBS) are diverse and vary among regions. The modified Erasmus GBS Outcome Score (mEGOS), developed with data from Dutch patients, is a clinical model that predicts the risk of walking inability in patients wit...
Helle Al-Hakem, Alex Y. Doets, Amro Stino, Sasha Živković et al.
<h3>Objective:</h3> To investigate cerebrospinal fluid findings in relation to clinical and electrodiagnostic subtypes, severity, and outcome of Guillain-Barré syndrome based on 1500 patients in the International GBS Outcome Study. <h3>Methods:</h3> Albuminocytological dissociation was defined as an...
Sonja E. Leonhard, Nowshin Papri, Luís Querol, Simon Rinaldi et al.
Guillain-Barré syndrome (GBS) is a rare immune-mediated polyradiculoneuropathy. Patients typically develop rapidly progressive weakness and sensory deficits that can result in complete paralysis requiring mechanical ventilation. GBS is usually a monophasic disease in which an aberrant immune respons...
Robin C.M. Thomma, Susan K. Halstead, L.C. de Koning, Evelin E J A Wiegers et al.
Guillain-Barré syndrome is an acute polyradiculoneuropathy in which preceding infections often elicit the production of antibodies that target peripheral nerve antigens, principally gangliosides. Anti-ganglioside antibodies are thought to play a key role in the clinical diversity of the disease and ...
Nowshin Papri, Zhahirul Islam, Gulshan Ara, Tamal Saha et al.
Abstract Background and Aims Considerable variation in clinical practice for management of Guillain‐Barré syndrome (GBS) has been observed worldwide. Diagnosis and treatment are challenging in low‐ and middle‐income countries (LMIC) due to lack of facilities and treatment availability. We aimed to e...
Shrebash Paul, Majeda Khanam, Md. Abdullah Saeed Khan, Sanzida Khan et al.
Rabies is one of the oldest and deadliest disease in the world and causes a significant number of deaths. Over 95% of all human deaths from rabies occur in Asia and Africa. Bangladesh is endemic to rabies. Since the National Rabies Elimination Program was successfully implemented in 2010, Bangladesh...
Sonja E. Leonhard, Annemiek A. van der Eijk, Hugh J. Willison, Bart C. Jacobs
We thank the readers for their comments on our article.1 The results of the International Guillain-Barré syndrome (GBS) Outcome Study (IGOS) do not reflect GBS statistics worldwide. We focused on 5 pathogens consistently associated with GBS in case-control studies and found similar distributions acr...
Sonja E. Leonhard, Melissa R. Mandarakas, Francisco de Assis Aquino Gondim, Kathleen Bateman et al.
Guillain-Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics i...